In Section A, individuals will acquire various doses and schedules of oral ABBV-744 tablet to detect Protected dosing routine. Additional individuals will probably be enrolled on the determined monotherapy dosign program. In Phase B, participants will obtain oral ruxolitinib and ABBV-744 might be given as "incorporate-on" therapy. In Section C, https://nikitac322nyj5.activoblog.com/profile